AOP Health
Petra Lanz has extensive experience in the pharmaceutical industry, with a background in sales, marketing, and management. Petra has held various leadership roles at companies like AOP Orphan Pharmaceuticals AG, Vertex Pharmaceuticals, AbbVie Austria, Biogen Idec Austria GmbH, and Wyeth Austria. Petra has a degree in pharmacy from the University of Vienna and Pharmazeutische Universität Wien.
This person is not in any offices
AOP Health
1 followers
Previously known as AOP Orphan, AOP Health is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the company has become an established provider of integrated therapy solutions from its headquarters in Vienna, its subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide. This development has been made possible by a continually high level of investment in research and development on the one hand and a highly consistent and pragmatic orientation towards the needs of all our stakeholders on the other - especially the patients and their families as well as also the doctors and care professionals treating them. Needs. Science. Trust. The international healthcare group focuses on research, development and global sales of innovative treatment solutions. AOP Health believes it has a responsibility to make innovative integrated therapies and disease-management solutions available long term to as many patients as possible who suffer from rare diseases or require critical care. Data protection information: https://www.aop-health.com/global_en/footer/privacy-policy